Congress Asset Management’s Neurocrine Biosciences NBIX Stock Holding History

Congress Asset Management’s Portfolio NBIX Stock Details NBIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$13.9M	Buy	+82,486	New	+$12.2M	0.09%	185
2025 Q4	–	Sell	-2,690	Closed	-$378K	–	395
2025 Q3	$378K	Buy	+2,690	New	+$364K	﹤0.01%	364
2025 Q2	–	Sell	-2,363	Closed	-$261K	–	395
2025 Q1	$261K	Buy	+2,363	New	+$299K	﹤0.01%	355
2024 Q3	–	Sell	-2,855	Closed	-$393K	–	371
2024 Q2	$393K	Buy	+2,855	New	+$392K	﹤0.01%	346
2023 Q4	–	Sell	-4,229	Closed	-$476K	–	381
2023 Q3	$476K	Sell	4,229 -1,543	-27%	-$162K	﹤0.01%	340
2023 Q2	$544K	Sell	5,772 -914,281	-99%	-$89.3M	﹤0.01%	327
2023 Q1	$93.1M	Buy	920,053 +2,228	+0.2%	+$232K	0.87%	53
2022 Q4	$110M	Sell	917,825 -176,352	-16%	-$20.7M	1.1%	25
2022 Q3	$116M	Buy	1,094,177 +20,335	+2%	+$2.06M	1.25%	17
2022 Q2	$105M	Sell	1,073,842 -37,006	-3%	-$3.42M	1%	38
2022 Q1	$104M	Buy	1,110,848 +201,760	+22%	+$17.1M	0.89%	53
2021 Q4	$77.4M	Sell	909,088 -102,684	-10%	-$9.45M	0.59%	74
2021 Q3	$97M	Buy	1,011,772 +63,207	+7%	+$5.97M	0.76%	72
2021 Q2	$92.3M	Buy	948,565 +46,731	+5%	+$4.48M	0.77%	72
2021 Q1	$87.7M	Buy	901,834 +140,893	+19%	+$14.8M	0.79%	68
2020 Q4	$72.9M	Sell	760,941 -6,709	-0.9%	-$648K	0.69%	76
2020 Q3	$73.8M	Buy	+767,650	New	+$88.8M	0.8%	69

Other funds holding NBIX

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

PBBUPS

PKO BP Bankowy Universal Pension Society Warsaw, Poland $350M AUM 272.18% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Amalgamated Bank New York $14.5B AUM 44.3% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Congress Asset Management's NBIX Position: Q2 2026 in Review

Congress Asset Management opened a new position in Neurocrine Biosciences (NBIX) in Q2 2026: 82,486 shares worth $13.9M. The stake represents 0.09% of the portfolio and ranks #185 among its holdings. This is a return to the name: Congress Asset Management previously reported a position in NBIX as recently as Q3 2025.

Congress Asset Management first reported a position in NBIX in Q3 2020 and has held it in 17 quarters since. The position peaked at $116M in Q3 2022. 166 funds tracked by Wall St. Rank hold NBIX as of Q2 2026.

Congress Asset Management held 82,486 shares of Neurocrine Biosciences worth $13.9M as of Q2 2026.
Neurocrine Biosciences was a new Congress Asset Management position in Q2 2026.
Neurocrine Biosciences made up 0.09% of Congress Asset Management's portfolio in Q2 2026, its #185 holding.
Congress Asset Management first reported a position in Neurocrine Biosciences in Q3 2020 and has held it in 17 quarters since.
Congress Asset Management's Neurocrine Biosciences position peaked at $116M in Q3 2022.
166 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q2 2026.

Based on Congress Asset Management's 13F filing for Q2 2026, filed 7 Jul 2026.